1 / 48

STAMMZELLEN

Learn how stem cell strategies address immunological issues through patient-derived tissue transplants, including cord blood multipotent uses and endothel's role. Explore research advancements in neurobiology and hematology for better clinical applications.

rschott
Download Presentation

STAMMZELLEN

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. STAMMZELLEN BLASTOMERE TOTIPOTENT I C M PLURIPOTENT KNOCHENMARK MULTIPOTENT CORD BLOOD MULTIPOTENT

  2. Endothel

  3. Despite their advantages, transplantation and stem-cell strategies still suffer from the problem of immunological incompatibility, a problem that could be avioded if material derived from patients own tissues could be transplanted into them.

  4. Embryonale StammzellenKlonenAlternativen zum Klonen

  5. Das Ambientemoduliertdie Progenitorzelle

  6. CORD BLOOD STAMMZELLEN KEINE FREMD - DNA NORMALE TELOMERE KEINE MITOCHONDRIALE SCHÄDEN

  7. CORD BLOOD ALS ERGÄNZUNG ZUR KNOCHENMARKS- TRANSPLANTATION ZUR AUTOLOGEN VERWENDUNG

  8. NACHTEIL DES CORD BLOOD GERINGE ZELLZAHL

  9. Turning Brain into Blood – Clinical Applications of Stem-Cell Research in Neurobiology and Hematology Malcolm A.S. Moore, The New England Journal of Medicine, 1999,341:605

  10. Graviditäts-ReplacementTherapie

  11. Local Perivascular Delivery of Basic Fibroblast Growth Factor in Patients Undergoing Coronary Bypass Surgery Results of o Phase I Randomized, Double-Blind, Placebo-Controlled Trial Roger J. Laham, Frank W. Sellke, Michael Simons Circulation 1999; 100: 1865-1871

More Related